Results 251 to 260 of about 37,178 (276)

Warfarin dose requirement and CYP2C9 polymorphisms

Lancet, The, 1999
Guruprasad P Aithal, Ann K Daly
exaly   +2 more sources

Effects of CYP2C9*3 and *13 alleles on the pharmacokinetics and pharmacodynamics of glipizide in healthy Korean subjects

Archives of Pharmacal Research, 2021
Chang-Keun Cho, Yun Jeong Lee, Jung-Woo Bae   +2 more
exaly  

Physiologically based pharmacokinetic (PBPK) modeling of piroxicam with regard to CYP2C9 genetic polymorphism

Archives of Pharmacal Research, 2022
Chang-Keun Cho, Yun Jeong Lee, Choon-Gon Jang   +2 more
exaly  

Comparative interaction analysis of CYP2C9, CYP2C9*2 and CYP2C9*3 proteins using molecular docking approach

2019
Yadav, Anamika, Katara, Pramod
openaire   +1 more source

CYP2C9 Gene

2020
openaire   +1 more source

Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications

Lancet, The, 1999
Guruprasad P Aithal, Ann K Daly
exaly  

CYP2C9*3 allelic variant and bleeding complications

Lancet, The, 1999
Stephen E Humphries
exaly  

CYP2C9 allelic variants: ethnic distribution and functional significance

Advanced Drug Delivery Reviews, 2002
Hong-Guang Xie, Richard B Kim, C Michael Stein   +2 more
exaly  

Determinants of the Inhibition of DprE1 and CYP2C9 by Antitubercular Thiophenes

Angewandte Chemie - International Edition, 2017
Renhe Liu, Sarah M Batt, Catherine Vilcheze   +2 more
exaly  

CYP2C9*3, CYP2C9*2 alleles modulate sensitivity to acenocoumarol

Inpharma Weekly, 2002
openaire   +1 more source